BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3876162)

  • 1. The generation of effector T cells in influenza A-infected, cyclosporine A-treated mice.
    Schiltknecht E; Ada GL
    Cell Immunol; 1985 Oct; 95(2):340-8. PubMed ID: 3876162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different functions of subsets of effector T cells in murine influenza virus infection.
    Leung KN; Ada GL
    Cell Immunol; 1982 Mar; 67(2):312-24. PubMed ID: 6979396
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo collaboration between precursor T cells and helper T cells in the development of delayed-type hypersensitivity reaction to influenza virus in mice.
    Leung KN; Schiltknecht E; Ada GL
    Scand J Immunol; 1982 Sep; 16(3):257-64. PubMed ID: 6216581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza virus-specific T cells fail to reduce lung virus titres in cyclosporin-treated, infected mice.
    Schiltknecht E; Ada GL
    Scand J Immunol; 1985 Jul; 22(1):99-103. PubMed ID: 3875147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo effects of cyclosporine on influenza A virus-infected mice.
    Schiltknecht E; Ada GL
    Cell Immunol; 1985 Mar; 91(1):227-39. PubMed ID: 2982505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of DTH in the mouse to influenza virus: comparison with conditions for stimulation of cytotoxic T cells.
    Leung KN; Ada GL
    Scand J Immunol; 1980; 12(2):129-39. PubMed ID: 6255555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity, Ly phenotype, and H-2 compatibility requirements of effector cells in delayed-type hypersensitivity responses to murine influenza virus infection.
    Leung KN; Ada GL; McKenzie IF
    J Exp Med; 1980 Apr; 151(4):815-26. PubMed ID: 6966309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of cyclosporine-induced suppressor cells in murine delayed-type hypersensitivity responses.
    Mirisklavos A; Mottram PL; Dumble LJ; Clunie GJ
    Int Arch Allergy Appl Immunol; 1986; 79(2):215-9. PubMed ID: 2935501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed-type hypersensitivity to influenza virus. Induction of antigen-specific suppressor T cells for delayed-type hypersensitivity to hemagglutinin during influenza virus infection in mice.
    Liew FY; Russell SM
    J Exp Med; 1980 Apr; 151(4):799-814. PubMed ID: 6154762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of secondary cytotoxic T-cell responses in mice infected with influenza A viruses.
    Effros RB; Bennink J; Doherty PC
    Cell Immunol; 1978 Mar; 36(2):345-53. PubMed ID: 75768
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunologic recognition of influenza virus-infected cells. I. Generation of a virus-strain specific and a cross-reactive subpopulation of cytotoxic T cells in the response to type A influenza viruses of different subtypes.
    Braciale TJ
    Cell Immunol; 1977 Oct; 33(2):423-36. PubMed ID: 303150
    [No Abstract]   [Full Text] [Related]  

  • 12. Do L3T4+ T cells act as effector cells in protection against influenza virus infection.
    Lightman S; Cobbold S; Waldmann H; Askonas BA
    Immunology; 1987 Sep; 62(1):139-44. PubMed ID: 2820868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of cyclosporin on major histocompatibility complex-linked resistance to murine cytomegalovirus.
    Lawson CM; Hodgkin PD; Shellam GR
    J Gen Virol; 1989 May; 70 ( Pt 5)():1253-9. PubMed ID: 2543779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of augmented resistance of cyclosporin A-treated mice to influenza virus infection by trehalose-6,6'-dimycolate.
    Sazaki K; Yoshida I; Azuma M
    Microbiol Immunol; 1992; 36(10):1061-75. PubMed ID: 1282653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed-type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-type hypersensitivity effector T cells.
    Ptak W; Herzog WR; Askenase PW
    J Immunol; 1991 Jan; 146(2):469-75. PubMed ID: 1987274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporin A inhibits the delayed-type hypersensitivity effector function of T lymphocytes without affecting their clonal expansion.
    Milon G; Truffa-Bachi P; Shidani B; Marchal G
    Ann Immunol (Paris); 1984; 135D(3):237-45. PubMed ID: 6335647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of cyclosporine A in vivo. II. T cell priming in vivo to alloantigen can be mediated by an IL-2-independent cyclosporine A-resistant pathway.
    Pereira GM; Miller JF; Shevach EM
    J Immunol; 1990 Mar; 144(6):2109-16. PubMed ID: 1968924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local cellular defenses in influenza-infected lungs.
    Stein-Streilein J; Witte PL; Streilein JW; Guffee J
    Cell Immunol; 1985 Oct; 95(2):234-46. PubMed ID: 3876158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo effects of cyclosporine in the generation and expression of effector cell function.
    Schiltknecht E; Ada GL
    Transplant Proc; 1986 Apr; 18(2):357-9. PubMed ID: 3485846
    [No Abstract]   [Full Text] [Related]  

  • 20. Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells.
    Scherle PA; Palladino G; Gerhard W
    J Immunol; 1992 Jan; 148(1):212-7. PubMed ID: 1530795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.